Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Launched by UNIVERSITY OF PENNSYLVANIA · Jan 12, 2012

Keywords

ClinConnect Summary

This clinical trial is studying Cutaneous Lupus Erythematosus (CLE), a skin condition related to lupus that can cause rashes and other skin issues. The research aims to gather information about how common CLE is and how severe it can be. The study is being conducted at multiple sites, including the University of Pennsylvania and the University of Texas Southwestern, and it is currently looking for participants.

If you are 18 years or older and have been diagnosed with CLE or systemic lupus erythematosus (SLE), you may be eligible to join the trial. Participants can expect to provide information about their condition and may undergo certain evaluations to help researchers understand CLE better. It's important to note that this trial is not open to individuals under 18 or those who do not meet the specific criteria for CLE. By joining this study, participants can contribute to important research that could improve the understanding and treatment of this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older.
• Exclusion Criteria:
• • All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old